increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by Dr_Dan  – Germany, 2017-06-08 19:36 (2844 d 01:56 ago) – Posting: # 17466
Views: 14,925

O.k., I see I need to add some more information. The idea behind this question is to develop an oral formulation with a less drug load than the reference product but with the same bioavailability in order to decrease non-systemic adverse events.

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
21 visitors (0 registered, 21 guests [including 2 identified bots]).
Forum time: 20:33 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5